Literature DB >> 16533903

Follow-up of markedly elevated serum potassium results in the ambulatory setting: implications for patient safety.

Carlton R Moore1, Jenny J Lin, Nicky O'Connor, Ethan A Halm.   

Abstract

Failure to follow up outpatient test results in a timely manner is a growing patient safety concern. To investigate the follow-up of markedly elevated serum potassium levels in the ambulatory setting, the authors reviewed the medical records of all patients seen in a large primary care practice between September 1, 2003, and August 31, 2004, with potassium levels > or = 5.8 mEq/L. Of the 12,914 serum potassium tests performed, there were 109 cases of markedly elevated serum potassium levels in 86 patients. The median potassium level was 5.9 mEq/L (range, 5.8-7.3). More than half the patients were recalled to the clinic specifically for repeat testing; however, 25% of patients had no repeat tests until they were seen at routine follow-up visits. The median time to a repeat potassium level was 6 days (range, 0-445). Patients > or = 65 years old had a lower likelihood of having repeat testing within 1 week (odds ratio = 0.38, P = .03).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16533903     DOI: 10.1177/1062860605285047

Source DB:  PubMed          Journal:  Am J Med Qual        ISSN: 1062-8606            Impact factor:   1.852


  4 in total

Review 1.  Failure to follow-up test results for ambulatory patients: a systematic review.

Authors:  Joanne L Callen; Johanna I Westbrook; Andrew Georgiou; Julie Li
Journal:  J Gen Intern Med       Date:  2011-12-20       Impact factor: 5.128

Review 2.  Potassium: friend or foe?

Authors:  Aylin R Rodan
Journal:  Pediatr Nephrol       Date:  2016-05-18       Impact factor: 3.714

3.  The frequency of hyperkalemia and its significance in chronic kidney disease.

Authors:  Lisa M Einhorn; Min Zhan; Van Doren Hsu; Lori D Walker; Maureen F Moen; Stephen L Seliger; Matthew R Weir; Jeffrey C Fink
Journal:  Arch Intern Med       Date:  2009-06-22

4.  Risk of hyperkalemia in patients with moderate chronic kidney disease initiating angiotensin converting enzyme inhibitors or angiotensin receptor blockers: a randomized study.

Authors:  Eugenia Espinel; Jorge Joven; Iván Gil; Pilar Suñé; Berta Renedo; Joan Fort; Daniel Serón
Journal:  BMC Res Notes       Date:  2013-08-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.